ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Gross Profit
ÂĄ30.7B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Gross Profit
ÂĄ3T
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
9%
Daiichi Sankyo Co Ltd
TSE:4568
Gross Profit
ÂĄ1.3T
CAGR 3-Years
26%
CAGR 5-Years
18%
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Gross Profit
ÂĄ1.6T
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Gross Profit
ÂĄ805.2B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Gross Profit
ÂĄ1.4T
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
5%
No Stocks Found

ASKA Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
58.1B JPY
Industry
Pharmaceuticals

ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Gross Profit?
Gross Profit
30.7B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Gross Profit amounts to 30.7B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
10%

Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 7% over the past three years , 10% over the past five years .

Back to Top